Durham AC, Pillitteri CA, San Myint M, Valli VE. Two hundred three cases of equine lymphoma classified according to the World Health Organization (WHO) classification criteria. Vet Pathol. 2013;50(1):86–93. doi:10.1177/0300985812451603
Mair TS, Krudewig C. Mast cell tumours (mastocytosis) in the horse: a review of the literature and report of 11 cases. Equine Vet Educ. 2008;20(4):177–182. doi:10.2746/095777308X291804
Taylor SD, Pusterla N, Vaughan B, Whitcomb MB, Wilson WD. Intestinal neoplasia in horses. J Vet Intern Med. 2006;20(6):1429–1436. doi:10.1892/0891-6640(2006)20[1429:inih]2.0.co;2
Bouéres CS, Câmara ACL, Castro MB, et al. Malignant peripheral nerve sheath tumour with metastasis and expression of endothelial differentiation factors in a horse. Equine Vet Educ. 2017;30(12):e463–e467.
Kelley LC, Mahaffey EA. Equine malignant lymphomas: morphologic and immunohistochemical classification. Vet Pathol. 1998;35(4):241–252. doi:10.1177/030098589803500402
Valli VE. B-cell neoplasms. In: Veterinary Comparative Hematopathology. Blackwell; 2007:119–274.
Vander Werf K, Davis E. Disease remission in a horse with EHV-5-associated lymphoma. J Vet Intern Med. 2013;27(2):387–389. doi:10.1111/jvim.12050
Taintor J, Schleis S. Equine lymphoma. Equine Vet Educ. 2011;4:205–213.
Macon WR, Cousar JB, Waldron JA Jr, Hsu SM. Interleukin-4 may contribute to the abundant T-cell reaction and paucity of neoplastic B cells in T-cell-rich B-cell lymphomas. Am J Pathol. 1992;141(5):1031–1036.
Miller CA, Durham AC, Schaffer PA, Ehrhart EJ, Powers BE, Duncan CG. Classification and clinical features in 88 cases of equine cutaneous lymphoma. J Vet Diagn Invest. 2015;27(1):86–91. doi:10.1177/1040638714561653
Edwards GB, Proudman CJ. An analysis of 75 cases of intestinal obstruction caused by pedunculated lipomas. Equine Vet J. 1994;26(1):18–21. doi:10.1111/j.2042-3306.1994.tb04324.x
Bacci B, Stent AW, Walmsley EA. Equine intestinal lymphoma: clinical-pathological features, immunophenotype, and survival. Vet Pathol. 2020;57(3):369–376. doi:10.1177/0300985820906889
Advertisement
An 18-year-old 688-kg Belgian gelding was presented for chronic weight loss and a recent deterioration of its general condition.
On initial assessment, the horse had a rectal temperature of 39.0 °C (reference range, 37.2 to 38.3 °C), heart rate of 100 beats/min (reference range, 28 to 44 beats/min), and shallow respirations with clinically normal bronchovesicular sounds. Intestinal sounds were also clinically normal. There was frothy discharge from the oral cavity, and feces were slightly liquid. Ceftiofur (6.6 mg/kg, IM, q 96 h), moxidectin-praziquantel (dose not reported, PO), and flunixin meglumine (1.1 mg/kg, IV) were initially
In collaboration with the American College of Veterinary Pathologists